• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的肝外并发症。

Extrahepatic Complications of Nonalcoholic Fatty Liver Disease.

机构信息

Department of Medicine, Albert Einstein College of Medicine, 111 East 210th Street, Rosenthal 2C, Bronx, NY 10467, USA.

Department of Medicine, Albert Einstein College of Medicine, 111 East 210th Street, Rosenthal 2C, Bronx, NY 10467, USA.

出版信息

Clin Liver Dis. 2016 May;20(2):387-401. doi: 10.1016/j.cld.2015.10.004. Epub 2016 Feb 18.

DOI:10.1016/j.cld.2015.10.004
PMID:27063276
Abstract

Nonalcoholic fatty liver disease (NAFLD) is an important cause of liver disease that is often associated with the metabolic syndrome. There is a growing awareness that extrahepatic complications occur in individuals with NAFLD, especially an increased risk of cardiovascular disease. Development of diabetes mellitus, chronic kidney disease, colorectal cancer, and endocrinopathies has been linked to NAFLD. This article reviews the extrahepatic complications affecting individuals with NAFLD and the pathogenesis underlying their development.

摘要

非酒精性脂肪性肝病(NAFLD)是一种重要的肝病病因,常与代谢综合征相关。人们越来越意识到,NAFLD 患者会发生肝外并发症,尤其是心血管疾病风险增加。糖尿病、慢性肾脏病、结直肠癌和内分泌疾病的发生与 NAFLD 相关。本文综述了影响 NAFLD 患者的肝外并发症及其发病机制。

相似文献

1
Extrahepatic Complications of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的肝外并发症。
Clin Liver Dis. 2016 May;20(2):387-401. doi: 10.1016/j.cld.2015.10.004. Epub 2016 Feb 18.
2
Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander.非酒精性脂肪性肝病的全身并发症:当肝脏并非无辜旁观者时
Semin Liver Dis. 2015 Aug;35(3):236-49. doi: 10.1055/s-0035-1562944. Epub 2015 Sep 17.
3
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.非酒精性脂肪性肝病及其与心血管病和其他肝外疾病的关系。
Gut. 2017 Jun;66(6):1138-1153. doi: 10.1136/gutjnl-2017-313884. Epub 2017 Mar 17.
4
Nonalcoholic fatty liver disease as a multi-systemic disease.非酒精性脂肪性肝病作为一种多系统疾病。
World J Gastroenterol. 2016 Apr 28;22(16):4079-90. doi: 10.3748/wjg.v22.i16.4079.
5
Nonalcoholic fatty liver disease - A multisystem disease?非酒精性脂肪性肝病——一种多系统疾病?
World J Gastroenterol. 2016 Nov 21;22(43):9488-9505. doi: 10.3748/wjg.v22.i43.9488.
6
Extrahepatic complications of non-alcoholic fatty liver disease: Its impact beyond the liver.非酒精性脂肪性肝病的肝外并发症:其对肝脏以外的影响。
Rev Gastroenterol Mex (Engl Ed). 2019 Oct-Dec;84(4):472-481. doi: 10.1016/j.rgmx.2019.05.004. Epub 2019 Sep 2.
7
Nonalcoholic Fatty Liver Disease and Liver Transplantation.非酒精性脂肪性肝病与肝移植。
Clin Liver Dis. 2016 May;20(2):403-17. doi: 10.1016/j.cld.2015.10.014.
8
[Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases].[非酒精性脂肪性肝病作为代谢综合征的一个组成部分及其与其他肝外疾病的因果关系]
Orv Hetil. 2017 Dec;158(52):2051-2061. doi: 10.1556/650.2017.30936.
9
Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease.非酒精性脂肪性肝病肝外表现的评估与管理。
Clin Mol Hepatol. 2021 Apr;27(2):221-235. doi: 10.3350/cmh.2020.0239. Epub 2020 Dec 3.
10
NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.非酒精性脂肪性肝病与肝外合并症:多器官代谢综合征的现有证据。
Int J Environ Res Public Health. 2019 Sep 14;16(18):3415. doi: 10.3390/ijerph16183415.

引用本文的文献

1
Surrogate markers in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎中的替代标志物。
Med Pharm Rep. 2021 Nov;94(Suppl No 3):S34-S37. doi: 10.15386/mpr-2511. Epub 2021 Nov 29.
2
PINK1/Park2-Mediated Mitophagy Relieve Non-Alcoholic Fatty Liver Disease.PINK1/Park2 介导的线粒体自噬缓解非酒精性脂肪性肝病。
Physiol Res. 2024 Apr 30;73(2):253-263. doi: 10.33549/physiolres.934925.
3
Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms.非酒精性脂肪性肝病与结直肠肿瘤风险之间的相关性分析。
Front Pharmacol. 2022 Nov 9;13:1068432. doi: 10.3389/fphar.2022.1068432. eCollection 2022.
4
Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine.代谢组学在非酒精性脂肪性肝病诊断及中医药治疗中的应用
Front Pharmacol. 2022 Aug 25;13:971561. doi: 10.3389/fphar.2022.971561. eCollection 2022.
5
Nutritional Value, Phytochemical Potential, and Therapeutic Benefits of Pumpkin ( sp.).南瓜(品种)的营养价值、植物化学潜力及治疗益处
Plants (Basel). 2022 May 24;11(11):1394. doi: 10.3390/plants11111394.
6
Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus.2型糖尿病患者肝脏脂肪堆积的影响因素
World J Clin Cases. 2021 Sep 16;9(26):7717-7728. doi: 10.12998/wjcc.v9.i26.7717.
7
Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan-Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study.罗望子胰蛋白酶抑制剂在壳聚糖-乳清蛋白纳米粒子对高血糖指数饮食诱导肝损伤的有益作用:一项临床前研究。
Int J Mol Sci. 2021 Sep 15;22(18):9968. doi: 10.3390/ijms22189968.
8
Correlation Between 25 Hydroxyvitamin D Levels and Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.中国 2 型糖尿病患者 25 羟维生素 D 水平与非酒精性脂肪性肝病的相关性:一项横断面研究
Int J Gen Med. 2021 Jul 1;14:3099-3107. doi: 10.2147/IJGM.S319449. eCollection 2021.
9
Non-Alcoholic Fatty Liver Disease Is Associated with Kidney Glomerular Hyperfiltration in Adults with Metabolic Syndrome.非酒精性脂肪性肝病与代谢综合征成人患者的肾小球高滤过相关。
J Clin Med. 2021 Apr 16;10(8):1717. doi: 10.3390/jcm10081717.
10
Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?将非酒精性脂肪性肝病(NAFLD)重新命名为代谢功能障碍相关脂肪性肝病(MAFLD):肝脏疾病流行病学(LDE)系统能否助力这一转变?
J Clin Med. 2021 Jan 31;10(3):492. doi: 10.3390/jcm10030492.